ED50 and ED95 of Intranasal Dexmedetomidine in Pediatric Patients Undergoing Transthoracic Echocardiography Study
Status:
Unknown status
Trial end date:
2020-12-01
Target enrollment:
Participant gender:
Summary
The median effective dose (ED50) and ED95 of intranasal dexmedetomidine as a single bolus
have not been described for sedation in children undergoing transthoracic echocardiography
(TEE) study. This information is important to compare agents and to determine the most
effective sedative dose. The investigators performed a two-stage study to determine the ED50
and the ED95 of intranasal dexmedetomidine to investigate age-related differences in
participants undergoing transthoracic echocardiography study.